GPAT3
GPAT3 (glycerol-3-phosphate acyltransferase 3) is an endoplasmic reticulum enzyme that acylates glycerol-3-phosphate and lysophosphatidic acid in glycerolipid synthesis. It is also known as AGPAT9, AGPAT10, LPAAT-theta and MAG1. Browse Assay Genie's current range of GPAT3 research reagents below, or read on for the biology behind the target.
GPAT3 catalyses two acylation steps early in glycerolipid synthesis. It converts glycerol-3-phosphate to 1-acyl-sn-glycerol-3-phosphate, better known as lysophosphatidic acid (LPA), by adding an acyl group at the sn-1 position of the glycerol backbone. It also converts LPA into 1,2-diacyl-sn-glycerol-3-phosphate, or phosphatidic acid (PA), by adding an acyl group at the sn-2 position. UniProt further annotates the enzyme as protecting cells against lipotoxicity.
The NCBI Gene summary describes the GPAT3 gene as encoding a member of the lysophosphatidic acid acyltransferase protein family, with a role in the synthesis of triacylglycerol. Multiple alternatively spliced transcript variants have been identified, and they all encode the same protein. The GPAT3 protein is a membrane-associated enzyme of the endoplasmic reticulum and belongs to the 1-acyl-sn-glycerol-3-phosphate acyltransferase family. Its EC number is 2.3.1.15. The mouse and rat orthologs are both named Gpat3.
The nomenclature of this gene reflects its dual activity. HGNC groups it with both the 1-acylglycerol-3-phosphate O-acyltransferases and the glycerol-3-phosphate acyltransferases. Earlier names include 1-acylglycerol-3-phosphate O-acyltransferase 9 (lysophosphatidic acid acyltransferase, theta), with the symbols AGPAT9 and AGPAT10 and the alias LPAAT-theta. The current symbol, GPAT3, is the one used in most recent literature.
GPAT3 acylates glycerol-3-phosphate and LPA, making it a useful node for studying how phosphatidic acid and related glycerolipids are built.
The NCBI Gene summary links the enzyme to triacylglycerol synthesis, so it is relevant to studies of neutral lipid production.
UniProt annotates GPAT3 as protecting cells against lipotoxicity, which makes it a candidate for work on cellular responses to lipid overload.
As a member of the 1-acyl-sn-glycerol-3-phosphate acyltransferase family with two acylation activities, GPAT3 supports comparative work across related lipid enzymes.
GPAT3 converts glycerol-3-phosphate to lysophosphatidic acid by adding an acyl group at the sn-1 position. It also converts LPA to phosphatidic acid by acylation at the sn-2 position. It contributes to triacylglycerol synthesis and protects cells against lipotoxicity.
GPAT3 is also called AGPAT9, AGPAT10, LPAAT-theta, MAG1, MGC11324 and HMFN0839. Earlier HGNC names were 1-acylglycerol-3-phosphate O-acyltransferase 9 and its lysophosphatidic acid acyltransferase, theta, variant. Alternative splicing produces transcript variants that encode the same protein.
Yes. Mouse and rat both have an ortholog named Gpat3. Cross-species use of any GPAT3 antibody or other reagent depends on the product, so check the datasheet of any product for its validated reactivity.
Other glycerol-3-phosphate and acylglycerol-3-phosphate acyltransferases and related lipid-synthesis enzymes with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q53EU6; product specifications from Assay Genie datasheets.